REPORT SCOPE & OVERVIEW
The Biomaterials Market size was estimated USD 156.1 billion in 2022 and is expected to reach USD 501.2 billion by 2030 at a CAGR of 15.7% during the forecast period of 2023-2030.
Biomaterial refers to any substance or mixture of substances that can be synthetic or natural in origin. Biomaterials research is the study of biomaterials, which includes factors such as genetics, medicine, chemistry, and tissue engineering. These biomaterials communicate with biological systems in order to cure cardiovascular, dental, orthopaedic, and neurological disorders.
Rising demand for biomaterials in plastic surgery and wound healing applications
Plastic surgery and wound healing are two of the most prevalent applications for biomaterial-based products. Biomaterials are widely used in plastic surgery for implanting, reconstructing, healing, and concealing soft-tissue wounds, burns, or gaping holes in the human body in a natural and safe manner. In the future years, demand for biomaterials in plastic surgery and wound healing applications will be driven by innovations and technological breakthroughs, as well as the increased popularity of aesthetic cosmetic procedures.
Stringent clinical & regulatory processes
Biomaterial-based medical devices are strictly controlled in numerous places, including North America, Europe, and Asia, to assure their quality and efficacy. This is primarily due to the fact that majority of biomaterial-based medical devices are implantable. Before they can be marketed, all new biomaterials must demonstrate that they are safe and effective. In the United States, the FDA establishes tight criteria and regulations for the clearance procedure. Biomaterial-based products, such as implantable pacemakers, stents, and cardiac valves, are categorized as Class III devices by the FDA, posing the highest risk of sickness or harm. As a result, these devices are submitted to the premarket approval application process (the most stringent sort of device marketing application).
Increasing healthcare markets in emerging economies
The biomaterials market in emerging nations is predicted to increase significantly during the projected period. This can be attributed primarily to these countries' growing patient populations, increasing adoption of implantable devices, growing awareness of CVDs, rising disposable income, improving healthcare infrastructure, and the presence of less stringent regulatory guidelines (in comparison to developed countries).
Stringent guidelines and compatibility issues
IMPACT OF RUSSIAN UKRAINE WAR
The Russian-Ukrainian situation appears to be exacerbating the pandemic's impact on Ukrainian health, particularly mental health. Knowing that Ukraine's health-care system was substantial but frail. And, in the midst of the continuing COVID-19 pandemic, which has already put health systems and health care personnel under immense strain, such attacks have the potential to be considerably more disastrous for Ukraine. SURVEILLANCE SYSTEM FOR ATTACKS ON HEALTH CARE (SSA) reported an anticipated 158 attacks on health care facilities until the end of April 2022.
IMPACT OF ONGOING RECESSION
Covalon Technologies Ltd. maintains a modest direct sales organization in the United States that sells directly to acute care hospitals and related institutions. Companies' sales staff has had to adjust and modify their strategy as COVID-19 limits have been imposed on hospitals and those who can enter hospitals. As a result, their sales force has limited access to these customers. As a result of the impact of COVID-19 and the continuous slump in market conditions, they withdrew sales force in the United Kingdom and are now focusing on growth in the United States market.
In 2022, Polymers segment is expected to held the highest market share of 28.5% during the forecast period owing to the wide range of product usage. Moreover, the widespread availability of biopolymers and advanced polymers for bio-resorbable tissue fixation and other orthopedic applications is likely to increase the segment's revenue growth. Polymeric biomaterials are a key component in tissue engineering. Micro-manufacturing, surface modification, drug delivery, nanotechnology, and high-throughput screening are all contributing to the expansion of polymeric material utilization in the tissue engineering sector.
Implantable Cardiac Defibrillators
Ocular Tissue Replacement
Tissue Regeneration Materials
Bone Grafts & Substitutes
Joint Replacement Biomaterials
Bioresorbable Tissue Fixation Products
Fracture Healing Device
Internal Tissue Sealant
Facial Wrinkle Treatment
Soft Tissue Fillers
Peripheral Nerve Repair
Acellular Dermal Matrices
Neural Stem Cell Encapsulation
Hydrogel Scaffold for CNS Repair
Cortical Neural Prosthetics
In 2022, Orthopedic segment is expected to dominate the market growth of 23.2% during the forecast period due to their high load-bearing capacity. Also, market vendors' ongoing efforts to introduce innovative orthopedic implants are projected to drive revenue generation.
North America held a significant market share of around 38.2% in 2022 owing to the measures performed by various governmental and private organizations. The National Science Foundation and the National Institute of Standards and Technology, which give expertise and help on the use of biomaterials in biological applications. As a result, the usage of biomaterials in this region has expanded. Furthermore, favorable government policies and the presence of numerous big market players in this region have aided the regional market share.
Asia-Pacific is witness to expand fastest CAGR rate of 16.8% during the forecast period due to strategic initiativews adopted by the regional companies to reinforce their presence in local as well as global markets, Also, the biomaterials market in India is constantly booming. The orthopedic, dental, and cardiovascular biomaterials industries dominate the Indian biomaterials business.
Rest of Eastern Europe
Rest of Western Europe
Rest of Asia Pacific
Middle East & Africa
Rest of Middle East
Rest of Africa
Rest of Latin America
The major key players are Medtronic plc, Evonik Industries AG, Carpenter Technology Corporation, Berkeley Advanced Biomaterials, Invibio Ltd., Zimmer Biomet Holdings, Inc., BASF SE, Covalon Technologies Ltd., Stryker, Johnson & Johnson, Dentsply Sirona, CoorsTek Inc., GE Healthcare, Collagen Matrix, Inc., and Others.
Evonik Industries AG, in March 2022, EUDRATEC Fasteric, a platform for oral drug delivery technology that goes directly over the released target and is used for enteric fortification and rapid release in the upper smaller intestine, was formally introduced by Evonik Industries. This product development aided Evonik's growth by improving the biocompatibility, safety, and functioning of implanted items used by medical device customers.
Medtronic and GE Healthcare, in April 2022, Medtronic and GE Healthcare formed a cooperation to satisfy the particular needs and demand for care in ambulatory surgery centers (ASCs) and office-based laboratories. (OBLs). Customers will benefit from a wide selection of products, financial options, and exceptional assistance as a result of this new relationship.
|Market Size in 2022||US$ 156.1 Billion|
|Market Size by 2030||US$ 501.2 Billion|
|CAGR||CAGR of 15.7 % From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Product (Metallic, Natural, Ceramics, Polymers)
• By Application (Cardiovascular, Ophthalmology, Dental, Orthopedic, Wound Healing, Tissue Engineering, Plastic Surgery, Neurology, Others)
|Regional Analysis/Coverage||North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)|
|Company Profiles||Medtronic plc, Evonik Industries AG, Carpenter Technology Corporation, Berkeley Advanced Biomaterials, Invibio Ltd., Zimmer Biomet Holdings, Inc., BASF SE, Covalon Technologies Ltd., Stryker, Johnson & Johnson, Dentsply Sirona, CoorsTek Inc., GE Healthcare, Collagen Matrix, Inc.|
|Key Drivers||• Rising demand for biomaterials in plastic surgery and wound healing applications|
|Market Opportunity||• Increasing healthcare markets in emerging economies|
Ans: Biomaterials Market is anticipated to expand by 15.7% from 2023 to 2030.
Ans: USD 501.2 billion is expected to grow by 2030.
Ans: Biomaterials Market size was valued at USD 156.1 billion in 2022.
Ans: North America is dominating the market.
Ans: Increasing demand for biomaterials in plastic surgery and wound healing applications
TABLE OF CONTENT
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.2 Impact on major economies
18.104.22.168 United Kingdom
22.214.171.124 South Korea
126.96.36.199 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Biomaterials Market Segmentation, By Product
9. Biomaterials Market Segmentation, By Application
9.1.4 Implantable Cardiac Defibrillators
9.1.6 Vascular Grafts
9.2.1 Synthetic Corneas
9.2.2 Intraocular Lens
9.2.3 Contact Lens
9.2.4 Ocular Tissue Replacement
9.3.1 Tissue Regeneration Materials
9.3.2 Dental Implants
9.3.3 Bone Grafts & Substitutes
9.3.4 Dental Membranes
9.4.1 Joint Replacement Biomaterials
9.4.3 Bioresorbable Tissue Fixation Products
9.4.5 Spine Biomaterials
9.5 Wound Healing
9.5.1 Fracture Healing Device
9.5.2 Adhesion Barrier
9.5.3 Skin Substitutes
9.5.4 Internal Tissue Sealant
9.5.5 Surgical Hemostats
9.6 Tissue Engineering
9.7 Plastic Surgery
9.7.1 Facial Wrinkle Treatment
9.7.2 Soft Tissue Fillers
9.7.3 Craniofacial Surgery
9.7.4 Bioengineered Skins
9.7.5 Peripheral Nerve Repair
9.7.6 Acellular Dermal Matrices
9.8.1 Neural Stem Cell Encapsulation
9.8.2 Shunting Systems
9.8.3 Hydrogel Scaffold for CNS Repair
9.8.4 Cortical Neural Prosthetics
10. Regional Analysis
10.2 North America
10.2.1 North America Biomaterials Market by Country
10.2.2 North America Biomaterials Market by Product
10.2.3 North America Biomaterials Market by Application
10.2.4.1 USA Biomaterials Market by Product
10.2.4.2 USA Biomaterials Market by Application
10.2.5.1 Canada Biomaterials Market by Product
10.2.5.2 Canada Biomaterials Market by Application
10.2.6.1 Mexico Biomaterials Market by Product
10.2.6.2 Mexico Biomaterials Market by Application
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe Biomaterials Market by Country
10.3.1.2 Eastern Europe Biomaterials Market by Product
10.3.1.3 Eastern Europe Biomaterials Market by Application
10.3.1.4.1 Poland Biomaterials Market by Product
10.3.1.4.2 Poland Biomaterials Market by Application
10.3.1.5.1 Romania Biomaterials Market by Product
10.3.1.5.2 Romania Biomaterials Market by Application
10.3.1.6.1 Hungary Biomaterials Market by Product
10.3.1.6.2 Hungary Biomaterials Market by Application
10.3.1.7.1 Turkey Biomaterials Market by Product
10.3.1.7.2 Turkey Biomaterials Market by Application
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe Biomaterials Market by Product
10.3.1.8.2 Rest of Eastern Europe Biomaterials Market by Application
10.3.2 Western Europe
10.3.2.1 Western Europe Biomaterials Market by Country
10.3.2.2 Western Europe Biomaterials Market by Product
10.3.2.3 Western Europe Biomaterials Market by Application
10.3.2.4.1 Germany Biomaterials Market by Product
10.3.2.4.2 Germany Biomaterials Market by Application
10.3.2.5.1 France Biomaterials Market by Product
10.3.2.5.2 France Biomaterials Market by Application
10.3.2.6.1 UK Biomaterials Market by Product
10.3.2.6.2 UK Biomaterials Market by Application
10.3.2.7.1 Italy Biomaterials Market by Product
10.3.2.7.2 Italy Biomaterials Market by Application
10.3.2.8.1 Spain Biomaterials Market by Product
10.3.2.8.2 Spain Biomaterials Market by Application
10.3.2.9.1 Netherlands Biomaterials Market by Product
10.3.2.9.2 Netherlands Biomaterials Market by Application
10.3.2.10.1 Switzerland Biomaterials Market by Product
10.3.2.10.2 Switzerland Biomaterials Market by Application
10.3.2.11.1 Austria Biomaterials Market by Product
10.3.2.11.2 Austria Biomaterials Market by Application
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe Biomaterials Market by Product
10.3.2.12.2 Rest of Western Europe Biomaterials Market by Application
10.4.1 Asia Pacific Biomaterials Market by Country
10.4.2 Asia Pacific Biomaterials Market by Product
10.4.3 Asia Pacific Biomaterials Market by Application
10.4.4.1 China Biomaterials Market by Product
10.4.4.2 China Biomaterials Market by Application
10.4.5.1 India Biomaterials Market by Product
10.4.5.2 India Biomaterials Market by Application
10.4.6.1 Japan Biomaterials Market by Product
10.4.6.2 Japan Biomaterials Market by Application
10.4.7 South Korea
10.4.7.1 South Korea Biomaterials Market by Product
10.4.7.2 South Korea Biomaterials Market by Application
10.4.8.1 Vietnam Biomaterials Market by Product
10.4.8.2 Vietnam Biomaterials Market by Application
10.4.9.1 Singapore Biomaterials Market by Product
10.4.9.2 Singapore Biomaterials Market by Application
10.4.10.1 Australia Biomaterials Market by Product
10.4.10.2 Australia Biomaterials Market by Application
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific Biomaterials Market by Product
10.4.11.2 Rest of Asia-Pacific APAC Biomaterials Market by Application
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East Biomaterials Market by Country
10.5.1.2 Middle East Biomaterials Market by Product
10.5.1.3 Middle East Biomaterials Market by Application
10.5.1.4.1 UAE Biomaterials Market by Product
10.5.1.4.2 UAE Biomaterials Market by Application
10.5.1.5.1 Egypt Biomaterials Market by Product
10.5.1.5.2 Egypt Biomaterials Market by Application
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia Biomaterials Market by Product
10.5.1.6.2 Saudi Arabia Biomaterials Market by Application
10.5.1.7.1 Qatar Biomaterials Market by Product
10.5.1.7.2 Qatar Biomaterials Market by Application
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East Biomaterials Market by Product
10.5.1.8.2 Rest of Middle East Biomaterials Market by Application
10.5.2.1 Africa Biomaterials Market by Country
10.5.2.2 Africa Biomaterials Market by Product
10.5.2.3 Africa Biomaterials Market by Application
10.5.2.4.1 Nigeria Biomaterials Market by Product
10.5.2.4.2 Nigeria Biomaterials Market by Application
10.5.2.5 South Africa
10.5.2.5.1 South Africa Biomaterials Market by Product
10.5.2.5.2 South Africa Biomaterials Market by Application
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa Biomaterials Market by Product
10.5.2.6.2 Rest of Africa Biomaterials Market by Application
10.6 Latin America
10.6.1 Latin America Biomaterials Market by Country
10.6.2 Latin America Biomaterials Market by Product
10.6.3 Latin America Biomaterials Market by Application
10.6.4.1 Brazil Biomaterials Market by Product
10.6.4.2 Brazil Biomaterials Market by Application
10.6.5.1 Argentina Biomaterials Market by Product
10.6.5.2 Argentina Biomaterials Market by Application
10.6.6.1 Colombia Biomaterials Market by Product
10.6.6.2 Colombia Biomaterials Market by Application
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America Biomaterials Market by Product
10.6.7.2 Rest of Latin America Biomaterials Market by Application
11. Company Profile
11.1 Medtronic plc
11.1.1 Company Overview
11.1.3 Product/Products Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Evonik Industries AG
11.2.1 Company Overview
11.2.3 Product/Products Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 Carpenter Technology Corporation
11.3.1 Company Overview
11.3.3 Product/Products Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Berkeley Advanced Biomaterials
11.4.1 Company Overview
11.4.3 Product/Products Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Invibio Ltd.
11.5.1 Company Overview
11.5.3 Product/Products Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Zimmer Biomet Holdings, Inc.,
11.6.1 Company Overview
11.6.3 Product/Products Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 BASF SE
11.7.1 Company Overview
11.7.3 Product/Products Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Covalon Technologies Ltd.
11.8.1 Company Overview
11.8.3 Product/Products Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9.1 Company Overview
11.9.3 Product/ Products Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 Johnson & Johnson
11.10.1 Company Overview
11.10.3 Product/Products Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View
11.11 Dentsply Sirona
11.11.1 Company Overview
11.11.3 Product/Products Offered
11.11.4 SWOT Analysis
11.11.5 The SNS View
11.12 CoorsTek Inc.
11.12.1 Company Overview
11.12.3 Product/Products Offered
11.12.4 SWOT Analysis
11.12.5 The SNS View
11.13 GE Healthcare
11.13.1 Company Overview
11.13.3 Product/Products Offered
11.13.4 SWOT Analysis
11.13.5 The SNS View
11.14 Collagen Matrix, Inc.
11.14.1 Company Overview
11.14.3 Product/Products Offered
11.14.4 SWOT Analysis
11.14.5 The SNS View
12. Competitive Landscape
12.1 Competitive Bench marking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. USE Cases and Best Practices
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Osteoporosis Treatment Market size was estimated USD 12,100 million in 2022 and is expected to reach USD 16559.69 million By 2030 at a CAGR of 4.0% during the forecast period of 2023-2030.
The Medical Marijuana Market size was valued at USD 6.80 Bn in 2022 and is expected to reach USD 32.50 Bn by 2030, with a CAGR of 21.60% over the forecast period of 2023-2030.
The Remote Patient Monitoring (RPM) Market Size was valued at USD 51.4 billion in 2022, and is expected to reach USD 354.49 billion by 2030, and grow at a CAGR of 27.3% over the forecast period 2023-2030.
The 3D Printed Brain Model Market Size was valued at USD 32.82 million in 2022 and is expected to reach USD 109.11 million by 2030, and grow at a CAGR of 16.2% over the forecast period 2023-2030.
In 2022, The Diabetic Ulcer Treatment Market size amounted to USD 5.16 Billion & is estimated to reach USD 8.03 Billion by 2030 and increase at a compound annual growth rate of 5.7% between 2023 and 2030.
The Immunohistochemistry Market size was estimated USD 2.4 billion in 2022 and is expected to reach USD 3.7 billion by 2030 at a CAGR of 5.9% during the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone